NCT00004258
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +83 more
- Locations
-
- Indiana University Cancer Center Indianapolis, Indiana, United States
Clinical trial condition
Leukemia, B-Cell
Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.
1,389 public trials
159 recruiting studies
Leukemia, B-Cell trial results
NCT00569842
- Conditions
- Anemia, Anemia, Aplastic, Aplastic Anemia, +37 more
- Locations
-
- Indiana Universtiy Simon Cancer Center Indianapolis, Indiana, United States
NCT00589563
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +70 more
- Locations
-
- Banner Good Samaritan Medical Center Phoenix, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
NCT00003107
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +116 more
- Locations
-
- Indiana University Cancer Center Indianapolis, Indiana, United States
NCT00445731
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +96 more
- Locations
-
Not specified
- Conditions
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), +91 more
- Locations
-
- Chedoke-McMaster Hospitals Hamilton, Ontario, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
- Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada
- University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
NCT00920738
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +49 more
- Locations
-
- University of Minnesota Children's Hospital - Fairview Minneapolis, Minnesota, United States
NCT00621452
- Conditions
- B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +38 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Open-label Extension Study of Navitoclax in Subjects With Chronic Lymphocytic Leukemia (CLL)
NCT01557777
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- Site Reference ID/Investigator# 74036 La Jolla, California, United States
- Site Reference ID/Investigator# 74035 Los Angeles, California, United States
- Site Reference ID/Investigator# 74038 Pleasant Hill, California, United States
- Site Reference ID/Investigator# 74039 Santa Maria, California, United States
NCT00669318
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States
- Mayo Clinic Rochester, Minnesota, United States
- University of Virginia Cancer Center Charlottesville, Virginia, United States